Archives
-
Perospirone and Vascular Kv1.5: Study Insights
2026-08-26
The reference study identifies a previously unrecognized vascular ion-channel action of Perospirone: concentration-dependent inhibition of Kv currents in freshly isolated rabbit coronary arterial smooth muscle cells. Pharmacological profiling implicates Kv1.5, while the lack of use dependence or kinetic changes suggests an interaction distinct from voltage-sensor modulation and raises preclinical cardiovascular considerations for antipsychotic research.
-
Trichostatin A (TSA) in HDAC and Cancer Research
2026-08-26
Trichostatin A (TSA) is a reversible HDAC perturbation tool for linking histone acetylation to proliferation, cell-cycle control, and cytoskeletal behavior. This workflow-oriented guide shows how to use TSA as a benchmark treatment while testing the emerging connection between HDAC6 activity, α-tubulin lactylation, and microtubule dynamics.
-
TNF-alpha Recombinant Murine Protein Workflows
2026-08-25
Build reproducible apoptosis and inflammation assays with a trimeric, high-activity murine cytokine matched to cell-based research. This guide connects tumor necrosis factor alpha treatment with the latest RNA Pol II cell-death findings while emphasizing practical controls, dosing strategy, storage, and troubleshooting.
-
RIPA Lysis Buffer Strong: Practical Workflow
2026-08-25
RIPA Lysis Buffer Strong provides a detergent-rich starting system for extracting proteins from cultured animal cells and tissues, with no preadded protease or phosphatase inhibitors. It is appropriate for validated Western blot, immunoprecipitation, ELISA, and kinase workflows, but should be evaluated carefully when native protein complexes or detergent-sensitive enzyme activity must be preserved.
-
Palonosetron Hydrochloride in 5-HT3 Assays
2026-08-24
Build sharper 5-HT3A/5-HT3AB receptor assays and transporter workflows with a subnanomolar antagonist designed for mechanistic and translational studies. This guide connects concentration selection, washout experiments, renal transporter testing, and clinically relevant delayed-emesis biology.
-
Lambda Protein Phosphatase for BMAL1 Assays
2026-08-24
Use Lambda Protein Phosphatase to separate phosphorylation-dependent BMAL1 behavior from antibody artifacts, substrate loading effects, and condensate-buffer variables. This workflow connects controlled dephosphorylation with phospho-antibody validation, phosphorylation site validation, and phase-separation assays.
-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-08-23
A 2022 Journal of Molecular Medicine study identifies ziprasidone as a non-competitive inhibitor of GOT1, an enzyme that supports glutamine-derived redox metabolism in pancreatic ductal adenocarcinoma. By combining enzyme, metabolic, cellular, genetic, and xenograft experiments, the authors connect GOT1 inhibition with impaired proliferation, migration, redox imbalance, and tumor growth.
-
AMPK, Mitophagy, and Periodontal Inflammation
2026-08-22
A 2026 FASEB Journal study identifies AMPK as an upstream coordinator linking PINK1/Parkin-mediated mitophagy with NLRP3-driven inflammation in mechanically loaded diabetic periodontal tissue. Its in vivo and in vitro design suggests that restoring mitochondrial turnover may help explain how periodontal ligament fibroblasts respond to the combined stresses of mechanical force and high glucose.
-
Isorhamnetin and PI3K/Akt Control of Oocyte Maturation
2026-08-22
The reference study shows that Isorhamnetin improves porcine oocyte maturation while reducing oxidative stress, apoptosis-associated changes, mitochondrial dysregulation, and endoplasmic reticulum stress. Its main innovation is the connection of these protective effects with PI3K/Akt pathway activation, providing a mechanistic framework for studying oocyte quality during in vitro maturation.
-
Hypoxia, Choroid Plexus, and Cognitive Impairment
2026-08-21
This mouse study identifies choroid plexus barrier failure as a mechanistic bridge between simulated high-altitude hypoxia and cognitive dysfunction. Its proposed cascade links abnormal AMPK signaling and oxidative stress with M1 macrophage polarization, offering a focused framework for investigating neuroimmune responses to hypoxic stress.
-
Celastrol, CAV-1, and Mitophagy in Liver Cancer
2026-08-20
A 2026 Phytomedicine study identifies mitochondrial cholesterol overload as a previously underdefined link between celastrol exposure, mitophagy, and liver cancer suppression. By combining cholesterol localization assays, transcriptomics, protein-interaction studies, and xenograft validation, the work positions the CAV-1/SCP2 axis as a mechanistic regulator of organelle-specific lipid stress.
-
Selonsertib (GS-4997) in ASK1 Stress Signaling
2026-08-20
Selonsertib (GS-4997) provides a selective way to test whether ASK1-driven oxidative-stress signaling contributes to inflammation, fibrosis, and metabolic injury. This workflow connects pathway inhibition with the Galectin-1–FIP200 autophagy findings while clearly separating established evidence from exploratory liver-disease applications.
-
Angiotensin 1/2 (5-7): Assay Interpretation Guide
2026-08-19
Angiotensin 1/2 (5-7) is a compact H2N-Ile-His-Pro-OH peptide for studying fragment-specific renin-angiotensin biology. This guide explains how to interpret cardiovascular and spike-receptor binding data without confusing biochemical activity with clinical or infectious-disease causation.
-
MLN2238: Designing Causal Proteostasis Assays
2026-08-19
MLN2238 is a potent proteasome β5 subunit inhibitor for dissecting proteotoxic stress, apoptosis, and adaptive signaling. This guide translates ROS–JNK–CREB findings into more informative assay designs for oncology and proteostasis research.
-
Dextromethorphan hydrobromide Research Workflows
2026-08-18
Build reproducible excitotoxicity, calcium-signaling, and ischemia workflows with a research-grade NMDA receptor antagonist. This guide pairs practical handling advice with orthogonal assay design, helping distinguish receptor-mediated neuroprotection from nonspecific ion-channel or vehicle effects.